Accepted Manuscripts                   Back to the articles list | Back to browse issues page

XML Print

Abstract:   (165 Views)
This study evaluated the anticonvulsant activity of the add-on Drimia maritima (Squill) Oxymel, used traditionally in the treatment of convulsion, in animal model. Albino mice pretreated with squill Oxymel in different doses of 50, 100, 200, 400 mg/kg by oral gavage, 15 minutes prior to injection of pentylenetetrazole (PTZ). Animals pretreated with flumazenil to determine the mechanism of anticonvulsant action. The total flavonoid content of squill oxymel was also determined. Squill oxymel prolonged the onset of seizures and decreased the duration of seizures compared to control group. Diazepam used as a reference drug for its anticonvulsive effects, showed complete inhibition of seizure. This study revealed that squill oxymel has significant anticonvulsant effect in PTZ-induced seizures in mice, and these effects may be related to its effect on benzodiazepines’ receptors on GABA complex. These results confirmed the traditional use of squill oxymel in Iranian traditional medicine (ITM) for treatment of epilepsy. The clarification of mechanisms involved needs further studies.

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.